Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Talpaz

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Cancer Research|April 19, 2007
Degrasyn activates proteasomal-dependent degradation of c-MycGeoffrey Bartholomeusz, Moshe Talpaz, William Bornmann, et al.
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Effects of Calreticulin Mutations on HLA Class I Expression in Myeloproliferative NeoplasmsAmanpreet Kaur, Harini Desikan, Grace Pagnucco, et al.
Blood|March 29, 2003
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemiaStefan Faderl, David Harris, Quin Van, et al.
Cancer|November 25, 2003
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responsesHillary H Wu, Moshe Talpaz, Richard E Champlin, et al.
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Cancer|July 25, 2003
Chronic myelogenous leukemia: a review and update of therapeutic strategiesGuillermo Garcia-Manero, Stefan Faderl, Susan O'Brien, et al.
Haematologica|October 15, 2020
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformationJames Ropa, Nirmalya Saha, Hsiangyu Hu, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Cancer Research|April 19, 2007
Degrasyn activates proteasomal-dependent degradation of c-MycGeoffrey Bartholomeusz, Moshe Talpaz, William Bornmann, et al.
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Effects of Calreticulin Mutations on HLA Class I Expression in Myeloproliferative NeoplasmsAmanpreet Kaur, Harini Desikan, Grace Pagnucco, et al.
Blood|March 29, 2003
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemiaStefan Faderl, David Harris, Quin Van, et al.
Cancer|November 25, 2003
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responsesHillary H Wu, Moshe Talpaz, Richard E Champlin, et al.
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Cancer|July 25, 2003
Chronic myelogenous leukemia: a review and update of therapeutic strategiesGuillermo Garcia-Manero, Stefan Faderl, Susan O'Brien, et al.
Haematologica|October 15, 2020
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformationJames Ropa, Nirmalya Saha, Hsiangyu Hu, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Pageof 27